Term
| Asthma spirometry results |
|
Definition
|
|
Term
| Peak flow color system for asthma |
|
Definition
- GREEN - 80% of personal best signal good control
- YELLOW - 50-80%, must take short acting inhaled beta 2 agonists right away. See MD
- RED - below 50% of personal best, take agonists and see MD or ER |
|
|
Term
|
Definition
| increase of at least 12% and 200ml in either FVC or FEV1 after administration of a short acting bronchodilator |
|
|
Term
|
Definition
- intermittent
- persistent: mild, moderate, severe |
|
|
Term
|
Definition
Sx: less than or equal to 2 days/week
Nocturnal sx: less than or equal to 2x/month
SABA: less than or equal to 2 days/week
Interferes w/ normal activity: none
Step & tx:1 - SABA |
|
|
Term
|
Definition
Sx: greater than 2 days/week, but NOT DAILY
Nocturnal sx: 3-4x/month
SABA: greater than 2 days/week, but not daily and not more than once a day
Interferes w/ normal activity: minor
Step & tx:2 - low dose inhaled corticosteroid |
|
|
Term
| Asthma: Persistent Moderate |
|
Definition
Sx: daily
Nocturnal sx: greater than or equal to 1x/week, but not nightly
SABA: daily
Interferes w/ normal activity: some
Step & tx: 3 - low dose ICS + LABA
OR medium dose ICS
consider oral |
|
|
Term
| Asthma: Persistent Severe |
|
Definition
Sx: throughout the day
Nocturnal sx: often every day (7x/week)
SABA: several times a day
Interferes w/ normal activity: extreme
Step & tx: step 4 or 5 - (4) medium dose ICS + LABA
(5) high dose ICS + LABA
SEVERE = step 6 - add oral steroids |
|
|
Term
| CAP tx - healthy pts, no recent abx <60 y/o |
|
Definition
| - macrolide: azithromycin or DOXYCYCLINE, others = clarithromycin, erythromycin, or doxycycline |
|
|
Term
|
Definition
productive cough for 3 months or more in at least 2 consecutive years
- younger |
|
|
Term
|
Definition
abnormal permanent enlargement of alveoli
- older
- permanent enlargement of the air spaces distal to the terminal bronchiole without fibrosis. |
|
|
Term
|
Definition
- SMOKING
- give inactive flu vaccine
- respiratory hygiene: stay away from 2nd hand and allergens
- dyspnea on exertion (later at rest), sputum production, cough |
|
|
Term
|
Definition
ALL = FEV1/FVC<70%
1 - mild = FEV1> or equal to 80% predicted
2 - moderate = FEV1<80% but greater than or equal to 50% predicted
3 - severe = FEV1<50% but greater than or equal to 30% predicted
4 - very severe = FEV1<30% predicted or less than 50% predicted plus chronic respiratory failure |
|
|
Term
|
Definition
1 - SABA PRN
2 - anticholinergic or LABA, add rehab
3 - Add ICS
4 - add oxygen, consider surgery |
|
|
Term
|
Definition
|
|
Term
|
Definition
purified protein derivative
- check 48-72 hours
- noted w/in 2-10 weeks of acquiring organism |
|
|
Term
| PPD > or equal to 5 mm positive in? |
|
Definition
• HIV-infected persons
• A recent contact of a person
with tuberculosis (TB) disease
• Persons with fibrotic changes on
chest radiograph consistent
with prior TB
• Patients with organ transplants
• Persons who are immunosup-
pressed for other reasons (e.g., taking the equivalent of |
|
|
Term
| PPD > or equal to 10 mm positive in? |
|
Definition
|
|
Term
| PPD > or equal to 15 mm positive in? |
|
Definition
| any person, includ- ing persons with no known risk factors for TB. Targeted skin test- ing programs should be conducted only in high-risk groups, however |
|
|
Term
| Most common Pneumonia pathogen in adults? |
|
Definition
|
|
Term
| Tobacco user pneumonia agent? |
|
Definition
|
|
Term
| CAP tx - comorbidies (COPD, diabetes, HF, cancer, renal), older than 60, or recent abx |
|
Definition
- fluoroquinolone: levofloxacin, gemifloxacin, moxifloxacin
- OR betalactam (cephalosporins or ampicillin) + Macrolide (azithromycin) |
|
|
